AptarGroup to acquire 80% of Weihai Hengyu Medical Products

AptarGroup entered into an agreement to acquire 80% of the equity interests of Weihai Hengyu Medical Products, a Chinese manufacturer of elastomeric and plastic components for injectable drug delivery. The acquisition adds local manufacturing capacity in China.

“This majority equity investment is a strategic step that strengthens our competitive position in Asia and in the high-growth injectable drug delivery market.”investors.aptar.com

• 2 sources
• investors.aptar.comAptargroup, Inc. - Aptar Enters into Agreement with Weihai Hengyu Medical Products to Add Elastomeric and Plastic Component Manufacturing Capabilities in China for Injectable Drug DeliveryJul 28, 2021
• plasticsnews.comWeihai Hengyu Medical Products deal gives Aptar rubber and plastic medical manufacturing in China - Plastics NewsDon LoeppAug 2, 2021

Summarized from public sources; check the original articles before acting on it.